• Media type: E-Article
  • Title: Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin‐containing protein inhibitor
  • Contributor: Shikata, Yuki; Yoshimaru, Tetsuro; Komatsu, Masato; Katoh, Hiroto; Sato, Reiko; Kanagaki, Shuhei; Okazaki, Yasumasa; Toyokuni, Shinya; Tashiro, Etsu; Ishikawa, Shumpei; Katagiri, Toyomasa; Imoto, Masaya
  • Published: Wiley, 2017
  • Published in: Cancer Science, 108 (2017) 4, Seite 785-794
  • Language: English
  • DOI: 10.1111/cas.13175
  • ISSN: 1347-9032; 1349-7006
  • Keywords: Cancer Research ; Oncology ; General Medicine
  • Origination:
  • Footnote:
  • Description: <jats:p>Xanthohumol (<jats:styled-content style="fixed-case">XN</jats:styled-content>), a simple prenylated chalcone, can be isolated from hops and has the potential to be a cancer chemopreventive agent against several human tumor cell lines. We previously identified valosin‐containing protein (<jats:styled-content style="fixed-case">VCP</jats:styled-content>) as a target of <jats:styled-content style="fixed-case">XN</jats:styled-content>;<jats:styled-content style="fixed-case"> VCP</jats:styled-content> can also play crucial roles in cancer progression and prognosis. Therefore, we investigated the molecular mechanisms governing the contribution of <jats:styled-content style="fixed-case">VCP</jats:styled-content> to the antitumor activity of <jats:styled-content style="fixed-case">XN</jats:styled-content>. Several human tumor cell lines were treated with <jats:styled-content style="fixed-case">XN</jats:styled-content> to investigate which human tumor cell lines are sensitive to <jats:styled-content style="fixed-case">XN</jats:styled-content>. Several cell lines exhibited high sensitivity to <jats:styled-content style="fixed-case">XN</jats:styled-content> both <jats:italic>in vitro</jats:italic> and <jats:italic>in vivo</jats:italic>. sh<jats:styled-content style="fixed-case">RNA</jats:styled-content> screening and bioinformatics analysis identified that the inhibition of the adenylate cyclase (<jats:styled-content style="fixed-case">AC</jats:styled-content>) pathway synergistically facilitated apoptosis induced by <jats:styled-content style="fixed-case">VCP</jats:styled-content> inhibition. These results suggest that there is crosstalk between the <jats:styled-content style="fixed-case">AC</jats:styled-content> pathway and <jats:styled-content style="fixed-case">VCP</jats:styled-content> function, and targeting both <jats:styled-content style="fixed-case">VCP</jats:styled-content> and the <jats:styled-content style="fixed-case">AC</jats:styled-content> pathway is a potential chemotherapeutic strategy for a subset of tumor cells.</jats:p>
  • Access State: Open Access